Ann Rhoads
Directeur/Membre du Conseil chez REPARE THERAPEUTICS INC.
Fortune : 1 M $ au 30/04/2024
Profil
Ann D.
Rhoads is currently serving as an Independent Director at Globus Medical, Inc., Director at Myriad Women's Health, Inc., Director at iTeos Therapeutics SA, Independent Director at Repare Therapeutics, Inc., Independent Director at iTeos Therapeutics, Inc., and Independent Director at QuidelOrtho Corp.
Previously, she served as an Independent Director at Novellus Systems, Inc. from 2003 to 2012, Director at IRIDEX Corp.
from 2017 to 2018, Independent Director at Evoke Pharma, Inc. from 2013 to 2021, CFO, Secretary, Treasurer & Executive VP at Zogenix, Inc. from 2011 to 2017, Vice President at Sprout Group from 1993 to 1998, Chief Financial Officer at Premier, Inc. from 2000 to 2009, and Chief Financial Officer at Forty Seven, Inc. from 2018 to 2020.
Ms. Rhoads holds an undergraduate degree from The University of Arkansas and an MBA from Harvard Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2024 | 22 884 ( 0,02% ) | 1 M $ | 30/04/2024 | |
QUIDELORTHO CORPORATION
0,01% | 22/05/2024 | 4 496 ( 0,01% ) | 178 446 $ | 30/04/2024 |
REPARE THERAPEUTICS INC.
0,01% | 15/04/2024 | 4 000 ( 0,01% ) | 12 600 $ | 30/04/2024 |
ITEOS THERAPEUTICS, INC.
-.--% | 16/04/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Postes actifs de Ann Rhoads
| Sociétés | Poste | Début |
|---|---|---|
| GLOBUS MEDICAL, INC. | Directeur/Membre du Conseil | 29/07/2011 |
| ITEOS THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/06/2020 |
| REPARE THERAPEUTICS INC. | Directeur/Membre du Conseil | 10/06/2020 |
| QUIDELORTHO CORPORATION | Directeur/Membre du Conseil | 01/01/2020 |
iTeos Therapeutics SA
 iTeos Therapeutics SA Pharmaceuticals: MajorHealth Technology iTeos Therapeutics SA engages in the discovery of immunomodulators for cancer therapy. It operates as a biotechnology company which focuses on targeting metabolism of the tumor microenvironment through development of small-molecule immunomodulators for cancer treatment. The firm develops small molecules designed to target the tumor microenvironment by inhibiting cancer-induced immune suppression. Targeting such resistance mechanisms will enhance the clinical efficacy of both standards of care treatments as well as the newer immunomodulatory therapies based on the blockade of immune checkpoints. The company was founded in 2011 by Michel Detheux and Benoit Van den Eynde and is headquartered in Gosselies, Belgium. | Directeur/Membre du Conseil | 01/06/2020 |
Myriad Women's Health, Inc.
 Myriad Women's Health, Inc. Medical/Nursing ServicesHealth Services Myriad Women's Health, Inc. provides pre-pregnancy genetic testing services. It operates as a medical technology company that gives people access to vital information about their bodies, including DNA analysis for family preparation, and inherited cancers. The firm offers genetic counseling over the phone and gives client direct access to a professional genetics expert who can interpret their report. The company was founded by Ramji Srinivasan, Eric A. Evans, Rishi Kacker and Balaji S. Srinivasan on October 24, 2007 and is headquartered in South San Francisco, CA. | Directeur/Membre du Conseil | 04/01/2018 |
Innovatix LLC
 Innovatix LLC Miscellaneous Commercial ServicesCommercial Services Innovatix LLC provides group purchasing and consulting services. It offers negotiated contract discounts for various product categories, including blood products, capital equipment, enteral nutrition products and equipment, foodservice distribution, supplies and equipment, medical supplies, laboratory services and IT equipment and supplies. The company was founded in 1993 and is headquartered in New York, NY. | Directeur/Membre du Conseil | - |
Anciens postes connus de Ann Rhoads
| Sociétés | Poste | Fin |
|---|---|---|
| EVOKE PHARMA, INC. | Directeur/Membre du Conseil | 13/05/2021 |
| FORTY SEVEN, INC. | Directeur Financier/CFO | 07/04/2020 |
| ░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Ann Rhoads
| The University of Arkansas | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 7 |
|---|---|
| GLOBUS MEDICAL, INC. | Health Technology |
| EVOKE PHARMA, INC. | Health Technology |
| PREMIER, INC. | Health Services |
| IRIDEX CORPORATION | Health Technology |
| ITEOS THERAPEUTICS, INC. | Health Technology |
| REPARE THERAPEUTICS INC. | Health Technology |
| QUIDELORTHO CORPORATION | Health Technology |
| Entreprise privées | 10 |
|---|---|
Novellus Systems, Inc.
 Novellus Systems, Inc. Industrial MachineryProducer Manufacturing Novellus Systems, Inc. manufactures and services advanced automated wafer fabrication systems. The company was founded by Brad Mattson on April 11, 1984 and is headquartered in Fremont, CA. | Producer Manufacturing |
Innovatix LLC
Innovatix LLC Miscellaneous Commercial ServicesCommercial Services Innovatix LLC provides group purchasing and consulting services. It offers negotiated contract discounts for various product categories, including blood products, capital equipment, enteral nutrition products and equipment, foodservice distribution, supplies and equipment, medical supplies, laboratory services and IT equipment and supplies. The company was founded in 1993 and is headquartered in New York, NY. | Commercial Services |
Sprout Group
 Sprout Group Investment ManagersFinance Sprout Group (Sprout) is venture capital subsidiary of Credit Suisse Private Equity LLC founded in 1969. The firm headquartered in New York. | Finance |
Zogenix, Inc.
 Zogenix, Inc. Pharmaceuticals: MajorHealth Technology Zogenix, Inc. is a pharmaceutical company. The firm engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include Fintepla and MT1621. The company was founded by Stephen James Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA. | Health Technology |
YMCA of Greater Kansas City
 YMCA of Greater Kansas City Other Consumer ServicesConsumer Services The YMCA of Greater Kansas City, a non-profit organization with an inclusive environment committed to enriching the quality of family, spiritual, social, mental and physical well-being. grams. The company is headquartered in Kansas City, MO. | Consumer Services |
Myriad Women's Health, Inc.
Myriad Women's Health, Inc. Medical/Nursing ServicesHealth Services Myriad Women's Health, Inc. provides pre-pregnancy genetic testing services. It operates as a medical technology company that gives people access to vital information about their bodies, including DNA analysis for family preparation, and inherited cancers. The firm offers genetic counseling over the phone and gives client direct access to a professional genetics expert who can interpret their report. The company was founded by Ramji Srinivasan, Eric A. Evans, Rishi Kacker and Balaji S. Srinivasan on October 24, 2007 and is headquartered in South San Francisco, CA. | Health Services |
ALASTIN Skincare, Inc.
 ALASTIN Skincare, Inc. Household/Personal CareConsumer Non-Durables Alastin Skincare, Inc. develops and markets skin care products that reinvigorate, protect, and maintain healthy skin. It offers skin procedures such as injectables, laser resurfacing, microneedling, peels, photo rejuvination, radio frequency, skin tightening, surgical procedures, and ultra sound therapy. The company was founded by Scott L. Glenn and Cam L. Garner in 2015 and is headquartered in Carlsbad, CA. | Consumer Non-Durables |
Forty Seven, Inc.
 Forty Seven, Inc. Pharmaceuticals: MajorHealth Technology Forty Seven, Inc. develops therapies that target cancer immune evasion pathways. It develops Hu5F9-G4, a monoclonal antibody against human CD47 that potentially has applications spanning multiple tumor types and treatment modalities. The company was founded by Irving L. Weissman, Ravi Majeti, Mark Chao and Jens-Peter Volkmer in 2014 and is headquartered in Menlo Park, CA. | Health Technology |
iTeos Therapeutics SA
iTeos Therapeutics SA Pharmaceuticals: MajorHealth Technology iTeos Therapeutics SA engages in the discovery of immunomodulators for cancer therapy. It operates as a biotechnology company which focuses on targeting metabolism of the tumor microenvironment through development of small-molecule immunomodulators for cancer treatment. The firm develops small molecules designed to target the tumor microenvironment by inhibiting cancer-induced immune suppression. Targeting such resistance mechanisms will enhance the clinical efficacy of both standards of care treatments as well as the newer immunomodulatory therapies based on the blockade of immune checkpoints. The company was founded in 2011 by Michel Detheux and Benoit Van den Eynde and is headquartered in Gosselies, Belgium. | Health Technology |
Quidel Corp.
 Quidel Corp. Medical SpecialtiesHealth Technology Quidel Corp. engages in the development, manufacture and market of rapid diagnostic testing solutions. Its portfolio includes rapid immunoassays, cardiac immunoassays, specialized diagnostic solutions and molecular diagnostic solutions. The firm products are directly sold to end users and distributors and for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies and wellness screening centers. The company was founded in 1979 and is headquartered in San Diego, CA. | Health Technology |